| http://www.w3.org/ns/prov#value | - therapeutically effective amount of rapamycin or a rapamycin derivative having mTOR inhibiting properties, optionally in conjunction with one or more other active co-agents, e.g. as disclosed above. [0058] 1.7 A method for preventing or treating restenosis in diabetic patients comprising the
|
